Live courses

Title Credit Cost Datessort ascending
NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 CCM clock hours
    • 1.00 Participation
$0.00 01/22/2025 - 3:00pm to 4:00pm EST
Unraveling Cancer Pain Dynamics (City of Hope)
    • 4.00 AAPA Category 1 CME credit
    • 4.00 ACPE contact hours
    • 4.00 AMA PRA Category 1 Credit™
    • 4.00 ANCC contact hours
    • 4.00 ASWB continuing education credit
    • 4.00 Participation
$0.00 01/13/2025 - 2:00pm EST to 03/24/2025 - 3:00pm EDT
NCCN Tumor Boards: Treatment Selection Strategies and Barriers to Clinical Care in Metastatic Breast Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 CCM clock hours
    • 1.00 Participation
$0.00 01/13/2025 - 11:00am to 12:00pm EST
NCCN Pharmacy Updates: Advances in Neoadjuvant Treatment Options in Locally Advanced and Metastatic Rectal Cancer with Deficient Mismatch Repair
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 Participation
$0.00 12/19/2024 - 12:00pm to 1:00pm EST

Featured courses

Title Credit Type Event datesort ascending Cost
Plenary Session - Promising Practices to Reduce the Impact of Drug Shortages on Cancer Care
    • 1.25 AAPA Category 1 CME credit
    • 1.25 ASWB continuing education credit
    • 1.25 ACPE contact hours
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC contact hours
    • 1.25 Participation
Enduring $0.00
NCCN Guidelines® Insights - Prostate Cancer, Version 3.2024
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
Enduring $0.00
Renal Cell Carcinoma: Evolving Perspectives on Optimal Treatment
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 Participation
Enduring $0.00
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    • 2.00 ANCC contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ACPE contact hours
    • 2.00 AAPA Category 1 CME credit
    • 2.00 Participation
Enduring $0.00
Bispecific Antibodies: A New Frontier in Immunotherapy
    • 0.75 ANCC contact hours
      • 0.75 ANCC Pharmacology Contact Hours
    • 0.75 Participation
Enduring $0.00

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.